Nagham Ailabouni

Dr Nagham Ailabouni is a clinician-researcher and NHMRC Emerging Leadership Fellow at the University of Queensland, Faculty of Health, Medicine, and Behavioural Sciences. She is a 2026 Queensland Young Tall Poppy Award recipient.

Dr Ailabouni specialises in implementation science, deprescribing in people living with dementia and older people, and improving quality use of medicines in aged care. She is recognised for her expertise in co-designing resources that empower consumers to have informed conversations about their medicines with healthcare professionals. Dr Ailabouni is interested in understanding and studying strategies to bridge the deprescribing research to practice gap.

A registered pharmacist with clinical experience across hospital, community, and aged care healthcare settings, Dr Ailabouni completed their pharmacy degree and PhD in deprescribing (2018) from the University of Otago in New Zealand.

Leadership and recognition nationally and internationally:

• In 2026, Dr Ailabouni was the recipient of the Queensland Young Tall Poppy Award
• Dr Ailabouni was elected as the Public Engagement Subcommittee Chair for the Australian Deprescribing Network (2022–25)
• Dr Ailabouni was elected as Co-chair of the American Geriatrics Society Polypharmacy and Deprescribing Special Interest Group (2020–23)
• Dr Ailabouni was competitively selected as an Observer for the Australian Aged Care Quality and Safety Commission, Medication Safety Oversight Committee (2023–24)

Leadership and recognition at The University of Queensland, School of Pharmacy and Pharmaceutical Sciences:

• Dr Ailabouni served as the Early Career Representative (2022–24)
• In 2024, Dr Ailabouni received the Early Career Researcher award
• Dr Ailabouni was competitively selected as the Deputy Director of Research (2024-2025).

Dr Ailabouni is supervising PhD and Master of Philosophy students. She is passionate about mentoring early career researchers and expanding their supervision practice.